-
Sector Analysis
Atrial Fibrillation - Competitive Landscape in 2020
Anticoagulants and antiarrhythmic drugs are major focus of drug developers. There are 32 drugs in the pipeline, nine of which are ion channel blockers. Big pharma dominates R&D in this indication, with Bayer leading the way. Increasing prevalence expected to drive growth in atrial fibrillation market, but the promotion of generic drugs over branded options will limit the uptake of more expensive agents limiting the market growth.
-
Product Insights
Raynauds Disease - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Raynauds Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Pre-Eclampsia Disease - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Pre-Eclampsia Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Congenital Heart Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Congenital Heart Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Congenital Heart Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Congenital Heart Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Behcet Disease Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Behcet Disease Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Behcet Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Arrhythmias Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Arrhythmias Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Arrhythmias Clinical trials scenario. This report provides top line data relating to the clinical trials on Arrhythmias. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Hypotension Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Hypotension Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hypotension Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypotension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Atrial Fibrillation - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides an overview of the atrial fibrillation clinical trials scenario. This report provides top-line data relating to the clinical trials on atrial fibrillation. The report includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials (based on...
-
Product Insights
Myocardial Infarction Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Myocardial Infarction Global Clinical Trials Review, H1, 2020" provides an overview of Myocardial Infarction Clinical trials scenario. This report provides top line data relating to the clinical trials on Myocardial Infarction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Angina Pectoris - Epidemiology Forecast to 2028
Angina pectoris is a chest pain or discomfort often described as squeezing, pressure, heaviness, or tightness in the chest and is caused by reduced blood flow to the heart (Mayo Clinic, 2020). The reduced blood flow occurs when arteries that carry blood to the heart become narrowed and blocked because of a blood clot or atherosclerosis (Johns Hopkins Medicine, 2020). The reduced blood flow can also occur because of unstable plaques, poor blood flow through a narrowed heart valve, a...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.